Pharmaceuticals & Biotech

Cell and gene therapy 2.0

By Pranav Srivastava, Malik Kaman, and Romain Bonnot

July 12, 2023 | Webinar | 30-minute watch


In order to overcome the challenges currently facing cell and gene therapies (C&GT), the next generation of manufacturers must prepare to serve small and large patient populations across a wide range of care settings to harmonize clinical workflows, reduce HCP burden and deliver therapies at a fraction of the current cost. This cannot be achieved by incrementally tweaking the existing model. Rather, it requires leapfrogging the current C&GT 1.0 “proof-of-concept” to deliver fundamentally new capabilities. To deliver on the promise of C&GT 2.0, a new approach is required, one that considers the needs more holistically across the end-to-end patient journey.


In this webinar, you’ll learn about: 

  • Accelerating diagnosis to minimize the burden of disease
  • Enhancing patient outcomes to de-risk C&GT treatments
  • Reinforcing long-term impact to realize value creation

Add insights to your inbox

We’ll send you content you’ll want to read – and put to use.

About the author(s)